Only 2 left10 mg
NewAs per selected option
Triple GLP-1/GIP/glucagon receptor agonist for metabolic research.
In stock
Verified purity
Every batch is analysed for identity and purity before it ships.
Discreet packaging
Plain outer packaging with no product details visible from the outside.
Tracked delivery
Dispatch within one working day with tracked shipping across Europe.
For research purposes only. Not intended for human consumption. For use by professionals only.
Retatrutide (LY3437943) is a next-generation single-molecule peptide designed to activate three complementary metabolic receptors simultaneously - GLP-1, GIP and glucagon. Its triple-agonist profile is studied for effects on energy homeostasis, appetite regulation, thermogenesis, glucose and lipid metabolism, and body-composition markers in metabolic research models. Supplied as a sterile lyophilised vial; reconstitute with bacteriostatic water and store refrigerated between 2-8 °C once prepared.
Keep the sealed vial refrigerated between 2 and 8 °C and away from direct light. Do not freeze unless your protocol requires it.
Once reconstituted, keep the vial sealed and refrigerated, and aliquot rather than warming and cooling the same container repeatedly. Note the reconstitution date on the label.
Most products in the range ship as a lyophilised powder and need bacteriostatic water before use, which we stock separately.
For research purposes only. Not intended for human consumption. For use by professionals only.
Every batch is analysed for identity and purity before it ships.
Vials are stored and dispatched at 2-8 °C so they reach you in the condition they left us.
Dispatch within one working day with tracked shipping across Europe.
Reach a person on Telegram or by email, usually within a few hours.